当前位置: 首页 > 详情页

Chinese Cervicocephalic artery dissection study (CCADS): rationale and protocol for a multicenter prospective cohort study

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China. [2]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [3]China National Clinical Research Center for Neurological Diseases, Beijing, China. [4]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China. [5]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China. [6]Department of Neurology, Southwest Hospital, Third Military Medical University, Chongqing, China. [7]Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, China, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
出处:
ISSN:

关键词: Cervicocephalic artery dissection Cohort Risk factors Magnetic resonance imaging Biomarker Prognosis

摘要:
Background: Cervicocephalic artery dissection (CAD) is an important etiology of stroke in the youth. Findings from recent studies suggest it a "group of disease entities" with different underlying etiologies, presentations and prognosis, necessitating an integral study including various types of CAD to get a better understanding of this disease. In addition, Chinese patients with CAD are likely to carry different features from their western counterparts, which remains uncertain yet. Chinese Cervicocephalic Artery Dissection Study (CCADS) therefore aims at exploring the epidemiology, risk factors, clinical/radiological features, diagnosis and prognosis of CAD in Chinese patients. Methods/design: CCADS is a muiticenter prospective cohort study enrolling patients age >= 18 years with recent (<14 days after onset) CAD. Baseline clinical data, laboratory tests and imaging studies are performed within 3 days after admission, and follow-ups will be conducted through face-to-face interviews at discharge, 3 months, 6 months and 12 months after admission, when the modified Rankin Scale (mRS), cerebrovascular events, medication compliance, CAD evolution and so on are evaluated. Additional blood samples will also be collected at baseline, 3 and 12 months follow-up. The primary outcome is radiographic evolution of CAD; secondary outcomes include cerebrovascular events, major bleeding complications, all-cause mortality and functional independence. Discussion: Through the integration of information on epidemiology, risk factors, clinlcal/radiological features and prognosis of various types of CAD in Chinese population, combined with the application of advanced imaging techniques, collection of potential blood biomarkers, and assessment of novel treatment strategies. CCADS will provide thorough information on CAD - the major cause of stroke in the youth, and play a role in prevention and treatment determination in the future.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 临床神经病学
JCR分区:
出版当年[2016]版:
Q3 CLINICAL NEUROLOGY
最新[2023]版:
Q3 CLINICAL NEUROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Neurology, State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Neurology, State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17292 今日访问量:0 总访问量:929 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院